First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.1698 USD -4.61% Market Closed
Updated: Apr 28, 2024

ReShape Lifesciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReShape Lifesciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ReShape Lifesciences Inc
NASDAQ:RSLS
Cash from Operating Activities
-$17m
CAGR 3-Years
-18%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.4B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.5B
CAGR 3-Years
18%
CAGR 5-Years
52%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.3B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is ReShape Lifesciences Inc's Cash from Operating Activities?
Cash from Operating Activities
-17m USD

Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Cash from Operating Activities amounts to -17m USD.

What is ReShape Lifesciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
10%

Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for ReShape Lifesciences Inc have been -18% over the past three years , 10% over the past five years .